
09 Set Comunicazioni orali selezionate
Di seguito riportiamo l’elenco delle Comunicazioni Orali selezionate che saranno presentate a Roma. Tutti i poster inviati sono stati accettati per il Final Contest, la prossima settimana ne pubblicheremo l’elenco dettagliato.
L’ordine di presentazione delle singole relazioni a cura degli Autori sarà quanto prima comunicata con la pubblicazione del programma finale dell’evento previsto per le giornate del 29 e 30 settembre a Roma.
• ANTONELLI Alberto |Firenze • First detection of a multiresistance transposon of original structure harbouring cfr gene and a novel putative efflux pump in a linezolid-resistant MRSA
• BAI Francesca | Milano • Factors associated with anal/cervical HPV infection and dysplasia in a cohort of HIV-infected male and female patients
• BARTOLETTI Michele | Bologna • Bloodstream infection in cirrhotic patients: a prospective multicenter study (Bichrome)
• BERTOLDI Alessia | Bologna • Longitudinal evaluation of reservoir size decay in naïve HIV patients starting ART
• BOGLIONE Lucio | Torino • Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors
• BOZZI Giorgio | Milano • No Evidence of Ongoing Replication in Tissue Compartments During Combination Antiretroviral Therapy
• CANNIZZO Stefania E. | Milano • Role of microbial translocation in HIV infected patients during suppressive Antiretroviral Therapy (cART) and causal relationship with HIV-driven bone impairment
• CENTO Valeria | Roma • High efficacy of HCV resistance-guided retreatment strategies after protease inhibitors failure in real-life settings
• CORCIONE Silvia| Torino • Antimicrobial Stewardship in a Long Term Acute Care Hospital Using Offsite Electronic Medical Record Audit
• D’ABRAMO Alessandra | Roma • Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients
• DE PASCALIS Stefania | Napoli • ITPase activity modulates the severity of anemia in patients with hcv-related cirrhosis treated with ribavirin-containing IFN-free regimens
• DE ROSA Annalisa | Roma • Extensively drug resistant Pseudomonas aeruginosa: a study on carbapenem resistance mechanisms
• DEL PUENTE Filippo | Genova • Bone status evaluation by QUS in patients perinatally infected with HIV-1. A longitudinal study from childhood to early adult age
• DI CRISTO Valentina | Milano • Factors involved in continuance of atazanavir-based regimens : results from a cohort of HIV1-positive patients
• DI GENNARO Francesco | Bari • The sound of TB: role of lung ultrasound in the diagnosis and follow-up of pulmonary tuberculosis in resource limited settings
• FOCA’ Emanuele | Brescia • Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV co-infected patients with detectable HCV RNA. A MASTER Cohort study
• GIACOBBE Daniele Roberto | Genova • Lower sensitivity of serum (1,3)-beta-D-glucan for the diagnosis of candidemia due to Candida parapsilosis
• GIROMETTI Nicolò | Bologna • Outcomes of acutely HIV-1 infected individuals following rapid antiretroviral therapy initiation.
• IANNETTA Marco | Roma • Natalizumab affects T-cell phenotype in multiple sclerosis: implications for JCV reactivation
• LAGI Filippo | Firenze • Proposal for a New Score-Based Approach To Improve Efficiency of Diagnostic Laboratory Workflow for Acute Bacterial Meningitis in Adults
• MACERA Margherita | Napoli • CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection
• MALAGNINO Vincenzo | Roma • Emerging genotype E of Hepatitis B Virus in Young African migrants in Rome: new clinical and virological settings
• MAZZANTI Sara | Ancona • Epidemiologia, caratteristiche cliniche e mortalità della candidemia nell’età avanzata
• MAZZITELLI Maria | Catanzaro • Studio CARDIAC: (CARdiac DIseases in Antiviral therapy for HCV). Valutazione della funzionalità cardiaca in pazienti con infezione da HCV in trattamento con nuovi DAA
• MENOZZI Marianna | Modena • CD4/CD8 ratio matters to age related health outcomes in HIV infected patients with comorbidities, frailty and disability.
• MERLINI Esther | Milano • Association Between Mucosal-Associated Invariant T (MAIT) Cells and Gut Microbiome: Friend or Foe in Chronic Viral Infections?
• MUSUMECI Giuseppina | Bologna • M48U1 and Tenofovir combination synergistically inhibits HIV-1 infection in activated PBMCs and human cervicovaginal histocultures
• ONORATO Lorenzo | Napoli • Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study
• PASCALE Renato | Bologna • Tigecycline, an ecological choice? Retrospective cohort study of colonization or infection risk with Carbapenems-Resistant Klebsiella pneumoniae or Clostridium difficile following antibiotic treatment of intra-abdominal infection
• RINALDI Francesca | Pavia • Medical treatment versus “Watch and Wait” in the clinical management of CE3b echinococcal cysts of the liver
• RONZI Paola | Milano • Attività e tossicità in vitro dei composti peptidomimetici biciclici come inibitori della proteasi di HIV-1
• RUGGIERO Alessandra | Liverpool • During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR/DP/DQ
• SALADINI Francesco | Siena • Preliminary evaluation of antiviral activity of candidate HIV inhibitors targeting human DDX3 protein
• SATTA Giovanni | Londra • Genetic variation in Mycobacterium tuberculosis isolates from a London outbreak associated with isoniazid resistance
• STRAZZULLA Alessio | Catanzaro • Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?
• SVICHER Valentina | Roma • Identification and Characterization of Specific Genetic Elements in HBV Surface Glycoprotein correlated with Hepatocellular Carcinoma: An In Vivo and In Vitro Analysis
• TURRINI Filippo | Milano • The HIV-1 Transcriptional Repressor TRIM22 Is a Novel Determinant of Proviral Latency and Disease Progression
• VELOCI Sara | Firenze • HBV in gravidanza: analisi di una popolazione di 213 gestanti e valutazione dell’outcome dei nati da donne con elevata viremia presso l’Azienda Ospedaliero Universitaria Careggi, Firenze.
• VENANZI-RULLO Emmanuele | Messina • Amfotericina in aerosol per il trattamento dell’aspergillosi polmonare invasiva, uno studio di coorte retrospettivo osservazionale”
• ZAMMARCHI Lorenzo | Firenze • A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries
Sorry, the comment form is closed at this time.